Standard BioTools
LAB
LAB
109 hedge funds and large institutions have $252M invested in Standard BioTools in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
66% less capital invested
Capital invested by funds: $750M → $252M (-$498M)
Holders
109
Holding in Top 10
–
Calls
$12.8M
Puts
$7.69M
Top Buyers
| 1 | +$10.6M | |
| 2 | +$6.49M | |
| 3 | +$5.14M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.57M |
| 5 |
Goldman Sachs
New York
|
+$3.78M |
Top Sellers
| 1 | -$16.7M | |
| 2 | -$14.2M | |
| 3 | -$12.9M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$7.65M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.33M |